Similar to mammary Paget disease, most EMPD are positive for HER2, indicating the possibility that anti-HER2 therapy may be effective for the treatment of invasive and/or metastatic EMPD [7]. The gene discussed is ERBB2; the disease is extramammary Paget disease.